Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety

NCT01142284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease

Interventions

DRUG: Cilostazol, Probucol

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.